INTERNATIONAL PATENT: ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD., ANTENGENE BIOLOGICS LIMITED FILES APPLICATION FOR "NOVEL ANTIBODIES THAT BIND TO CD3 AND LILRB4 AND USES THEREOF"

GENEVA, June 16 -- ANTENGENE (HANGZHOU) BIOLOGICS CO., LTD. (Suite 1206-1209, Block B, Zhongshan SOHO Plaza, 1065 West Zhongshan RoadChangning District, Shanghai 200051), ANTENGENE BIOLOGICS LIMITED (Suite 1206-1209, Block B, Zhongshan SOHO Plaza, 1065 West Zhongshan RoadChangning District, Shanghai 200051) filed a patent application (PCT/CN2024/136968) for "NOVEL ANTIBODIES THAT BIND TO CD3 AND LILRB4, AND USES THEREOF" on Dec 05, 2024. With publication no. WO/2025/119253, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ...